Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levofolinic acid - Acrotech Biopharma

Drug Profile

Levofolinic acid - Acrotech Biopharma

Alternative Names: Calcium levofolinate; Calcium levoleucovorin; FUSILEV; Isovorin; KHAPZORY; Levofolinate; Levofolinate calcium; Levoleucovorin; Levoleucovorin calcium pentahydrate

Latest Information Update: 20 Mar 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wyeth
  • Developer Acrotech Biopharma
  • Class Antidotes; Antineoplastics; Formyltetrahydrofolates; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Colorectal cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Anaemia; Colorectal cancer; Osteosarcoma

Most Recent Events

  • 06 Mar 2019 Spectrum Pharmaceuticals completes sale of levofolinic acid to Acrotech Biopharma
  • 17 Jan 2019 Spectrum Pharmaceuticals and Acrotech Biopharma enters into a definitive agreement to sell Levofolinic acid
  • 08 Nov 2018 Spectrum Pharmaceuticals plans to launch levofolinic acid in first quarter of 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top